Bill Snyder

June 23, 2020

A connection to schizophrenia

The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found.

By Bill Snyder
June 18, 2020

Studying cells in reduced dimensions

Vanderbilt cell biologists have developed an unbiased, quantitative framework for evaluating single-cell data.

By Bill Snyder
June 18, 2020

Bhave, Grome receive awards at Research Forum

Gautam (Jay) Bhave, MD, PhD, assistant professor of Medicine and Cell & Developmental Biology, is the recipient of the 2020 Grant W. Liddle Award for “exemplary leadership in the promotion of scientific research” at Vanderbilt University Medical Center.

By Bill Snyder
June 17, 2020

Second forum on diversity and inclusion to be held June 23

The next virtual forum on diversity and inclusion for the Vanderbilt University Medical Center community will be held from 9-10 a.m. Tuesday, June 23.

By Bill Snyder
June 11, 2020

Online forum on diversity and inclusion attracts more than 750 from VUMC community

Led by André Churchwell, MD, Vice Chancellor of Equity, Diversity and Inclusion at Vanderbilt University and Chief Diversity Officer at VUMC, the hour-long conversation, spurred by the nation grappling with the death of George Floyd and other black Americans, was meant to encourage members of the VUMC community to discuss racism and unconscious bias, and offer an opportunity to support and engage with each other during this particularly difficult time.

By Bill Snyder
June 10, 2020

VUMC Office of Health Equity holds webinar on racism, health and health care

The nation is now focused on the deaths of black citizens in police custody but systemic racism permeates every facet of American society including health care, according to panelists who participated in a webinar presented last week by the Vanderbilt University Medical Center Office of Health Equity.

By Bill Snyder
June 9, 2020

Vanderbilt, AstraZeneca collaborate on new COVID-19 antibody research

After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.
By Bill Snyder
June 4, 2020

Potential new cancer target

Vanderbilt researchers have discovered the involvement of a certain type of adenosine receptor in mediating signaling that supports tumor growth and metastasis.
By Bill Snyder
June 4, 2020

Remdesivir helps reduce COVID-19 recovery time: study

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.
By Bill Snyder
May 27, 2020

Research probes why COVID-19 seems to spare young children

Lung disease experts at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.
By Bill Snyder
May 21, 2020

VUMC research ramps up in COVID-19 transition

As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center.
By Bill Snyder
May 21, 2020

Academy of Nutrition and Dietetics honors Silver

Heidi Silver, RDN, MS, PhD, an internationally known registered dietitian and nutrition scientist at VUMC, is the recipient of the 2020 Excellence in Research Practice Award from the Academy of Nutrition and Dietetics.
By Bill Snyder
1 … 38 39 40 41 42 … 115